Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Outset Medical, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

SAN JOSE, CALIF., AUG. 06, 2026 (GLOBE NEWSWIRE) -- OUTSET MEDICAL, INC. (NASDAQ: OM), A MEDICAL TECHNOLOGY COMPANY PIONEERING A FIRST-OF-ITS-KIND TECHNOLOGY TO IMPROVE CLINICAL OUTCOMES IN DIALYSIS WITH LESS COST AND COMPLEXITY, TODAY REPORTED FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2026.

OUTSET MEDICAL REPORTS SECOND QUARTER 2026 RESULTS

SHAREHOLDERS ARE URGED TO CONTACT THE FIRM IMMEDIATELY AT NO COST OR OBLIGATION, AS THERE MAY BE LIMITED TIME TO ENFORCE YOUR RIGHTS.  WE WOULD HANDLE THE MATTER ON A CONTINGENT FEE BASIS, WHEREBY YOU WOULD NOT BE RESPONSIBLE FOR OUT-OF-POCKET PAYMENT OF OUR LEGAL FEES OR EXPENSES.

DID OUTSET MEDICAL, INC. INSIDERS BREACH THEIR FIDUCIARY DUTIES TO SHAREHOLDERS?

SAN JOSE, CALIF., JULY 23, 2026 (GLOBE NEWSWIRE) -- OUTSET MEDICAL, INC. (NASDAQ: OM) (OUTSET), A MEDICAL TECHNOLOGY COMPANY PIONEERING A FIRST-OF-ITS-KIND TECHNOLOGY TO REDUCE THE COST AND COMPLEXITY OF DIALYSIS, TODAY ANNOUNCED THAT IT WILL RELEASE FINANCIAL RESULTS FOR THE SECOND QUARTER 2026 AFTER THE CLOSE OF TRADING ON THURSDAY, AUGUST 6, 2026.

OUTSET MEDICAL TO REPORT SECOND QUARTER 2026 FINANCIAL RESULTS ON THURSDAY, AUGUST 6, 2026

SAN JOSE, CALIF., JULY 02, 2026 (GLOBE NEWSWIRE) -- OUTSET MEDICAL, INC. (NASDAQ: OM), A MEDICAL TECHNOLOGY COMPANY PIONEERING A FIRST OF-ITS-KIND TECHNOLOGY TO IMPROVE CLINICAL OUTCOMES IN DIALYSIS WITH LESS COST AND COMPLEXITY (THE COMPANY), TODAY ANNOUNCED THAT THE COMPENSATION COMMITTEE OF ITS BOARD OF DIRECTORS APPROVED EQUITY AWARDS UNDER THE COMPANY'S INDUCEMENT PLAN, AS A MATERIAL INDUCEMENT TO EMPLOYMENT WITH THE COMPANY, FOR ONE RECENTLY HIRED EXECUTIVE EMPLOYEE AND TWO RECENTLY HIRED NON-EXECUTIVE EMPLOYEES, EACH OF WHOM WAS NOT PREVIOUSLY AN EMPLOYEE OR DIRECTOR OF THE COMPANY.

OUTSET MEDICAL REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

GENEVA--(BUSINESS WIRE)--OM PHARMA UNVEILS THE LARGEST MULTI-COUNTRY REAL-WORLD EVIDENCE STUDY ON BRONCHO VAXOM (OM 85) FOR RTI PREVENTION AT EAACI 2026.

OM PHARMA TO UNVEIL THE LARGEST MULTI-COUNTRY REAL-WORLD EVIDENCE STUDY ON BRONCHOVAXOM (OM85) FOR RTI PREVENTION AT EAACI 2026

MONTREAL, JUNE 09, 2026 (GLOBE NEWSWIRE) -- OSISKO METALS INCORPORATED (THE "COMPANY" OR "OSISKO METALS") ( TSX: OM ; OTCQX: OMZNF ; FRANKFURT: 0B51 ) IS PLEASED TO ANNOUNCE INITIAL RESULTS FROM THE 2026 DRILL PROGRAM AT THE GASP COPPER PROJECT, LOCATED IN THE GASP PENINSULA OF EASTERN QUBEC. FIVE DRILLS ARE CURRENTLY ACTIVE ON THE PROPERTY, WITH TWO ADDITIONAL DRILLS COMMENCING WORK THIS MONTH.

OSISKO INTERSECTS 80 METRES AVERAGING 1.93% CU AT GASP

TORONTO, MAY 29, 2026 (GLOBE NEWSWIRE) -- OSISKO METALS INCORPORATED (THE "COMPANY" OR "OSISKO METALS") (TSX: OM; OTCQX: OMZNF; FRANKFURT: OB51) IS PLEASED TO ANNOUNCE THE FILING ON SEDAR+ OF A TECHNICAL REPORT TITLED "NI 43-101 TECHNICAL REPORT ON THE GASP COPPER PROJECT WITH AN UPDATED MINERAL RESOURCE ESTIMATE FOR THE COPPER MOUNTAIN DEPOSIT, QUEBEC, CANADA" DATED MAY 28, 2026 (WITH AN EFFECTIVE DATE OF JANUARY 17, 2026) (THE "TECHNICAL REPORT"), IN ACCORDANCE WITH NATIONAL INSTRUMENT 43-101  STANDARDS OF DISCLOSURE FOR MINERAL PROJECTS ("NI 43-101").

OSISKO METALS FILES NI 43-101 TECHNICAL REPORT FOR THE GASP COPPER PROJECT

TORONTO, MAY 28, 2026 (GLOBE NEWSWIRE) -- OSISKO METALS INCORPORATED (TSX:OM "OSISKO" OR THE "CORPORATION") ANNOUNCES THE RESULTS OF ITS ANNUAL MEETING OF SHAREHOLDERS (THE "MEETING") HELD EARLIER TODAY. A TOTAL OF 475,369,374 COMMON SHARES OF THE CORPORATION WERE REPRESENTED AT THE MEETING, REPRESENTING APPROXIMATELY 64.4% OF THE TOTAL NUMBER OF COMMON SHARES OF THE CORPORATION ISSUED AND OUTSTANDING.

OSISKO METALS ANNOUNCES RESULTS OF VOTING AT 2026 ANNUAL MEETING OF SHAREHOLDERS AND WELCOMES KEITH MCKAY TO THE BOARD

SAN JOSE, CALIF., MAY 21, 2026 (GLOBE NEWSWIRE) -- OUTSET MEDICAL, INC. (NASDAQ: OM), A MEDICAL TECHNOLOGY COMPANY PIONEERING A FIRST OF-ITS-KIND TECHNOLOGY TO IMPROVE CLINICAL OUTCOMES IN DIALYSIS WITH LESS COST AND COMPLEXITY (THE COMPANY), TODAY ANNOUNCED THAT THE COMPENSATION COMMITTEE OF ITS BOARD OF DIRECTORS APPROVED EQUITY AWARDS UNDER THE COMPANY'S INDUCEMENT PLAN, AS A MATERIAL INDUCEMENT TO EMPLOYMENT TO TWO NEWLY APPOINTED NON-EXECUTIVE EMPLOYEES, IN EACH CASE, WHO WERE NOT PREVIOUS EMPLOYEES OR DIRECTORS OF THE COMPANY. THE EQUITY AWARDS WERE APPROVED IN ACCORDANCE WITH NASDAQ LISTING RULE 5635(C)(4), WHICH ALSO REQUIRES A PUBLIC ANNOUNCEMENT OF ANY EQUITY AWARDS THAT ARE NOT MADE UNDER A STOCKHOLDER APPROVED EQUITY PLAN.

Outset Medical, Inc.

OM

Price

Financial Reports

No items found.

Press Releases

Outset Medical, Inc.

OM.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financial Reports

No items found.

Press Releases

OM